Company Filing History:
Years Active: 2009
Title: The Innovations of Anders Sjohölm
Introduction
Anders Sjohölm is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biochemistry, particularly in the study of proteins and their roles in virulence. His work has implications for both analytical procedures and vaccine development.
Latest Patents
Anders Sjohölm holds a patent for a "Streptococcal inhibitor of complement-mediated lysis, protein SIC." This protein, characterized from serotype Ml, plays a crucial role in inhibiting hemolysis by interacting with plasma proteins such as clusterin and members of the cystatin protein superfamily, including histidine-rich glycoprotein (HRG). The patent details various partial amino acid sequences that comprise the protein, which can be utilized in analytical procedures to determine the presence of virulent Streptococcus pyogenes in samples. Additionally, the protein has potential applications in vaccine compositions.
Career Highlights
Anders Sjohölm is associated with Genovis AB, a company that focuses on innovative solutions in the field of biotechnology. His work at Genovis AB has allowed him to explore the applications of his research in practical settings, contributing to advancements in medical science.
Collaborations
Anders has collaborated with notable colleagues such as Per Åkesson and Lars Björck. These collaborations have further enriched his research and have led to significant advancements in their shared field of study.
Conclusion
Anders Sjohölm's contributions to the field of biochemistry, particularly through his patented work on protein SIC, highlight the importance of innovation in medical research. His efforts continue to pave the way for advancements in vaccine development and analytical procedures.